178 related articles for article (PubMed ID: 22393166)
1. Effect of genetic variation in LRRTM3 on risk of Alzheimer disease.
Reitz C; Conrad C; Roszkowski K; Rogers RS; Mayeux R
Arch Neurol; 2012 Jul; 69(7):894-900. PubMed ID: 22393166
[TBL] [Abstract][Full Text] [Related]
2. Association of LRRTM3 polymorphisms with late-onset Alzheimer's disease in Han Chinese.
Wang J; Yu JT; Jiang T; Tan MS; Wang HF; Tan L; Hu N; Sun L; Zhang W; Tan L
Exp Gerontol; 2014 Apr; 52():18-22. PubMed ID: 24463050
[TBL] [Abstract][Full Text] [Related]
3. LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD).
Lincoln S; Allen M; Cox CL; Walker LP; Malphrus K; Qiu Y; Nguyen T; Rowley C; Kouri N; Crook J; Pankratz VS; Younkin S; Younkin L; Carrasquillo M; Zou F; Abdul-Hay SO; Springer W; Sando SB; Aasly JO; Barcikowska M; Wszolek ZK; Lewis JM; Dickson D; Graff-Radford NR; Petersen RC; Eckman E; Younkin SG; Ertekin-Taner N
PLoS One; 2013; 8(6):e64164. PubMed ID: 23750206
[TBL] [Abstract][Full Text] [Related]
4. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
[TBL] [Abstract][Full Text] [Related]
5. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families.
Athan ES; Williamson J; Ciappa A; Santana V; Romas SN; Lee JH; Rondon H; Lantigua RA; Medrano M; Torres M; Arawaka S; Rogaeva E; Song YQ; Sato C; Kawarai T; Fafel KC; Boss MA; Seltzer WK; Stern Y; St George-Hyslop P; Tycko B; Mayeux R
JAMA; 2001 Nov; 286(18):2257-63. PubMed ID: 11710891
[TBL] [Abstract][Full Text] [Related]
6. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).
Reitz C; Tosto G; Vardarajan B; Rogaeva E; Ghani M; Rogers RS; Conrad C; Haines JL; Pericak-Vance MA; Fallin MD; Foroud T; Farrer LA; Schellenberg GD; George-Hyslop PS; Mayeux R;
Transl Psychiatry; 2013 May; 3(5):e256. PubMed ID: 23673467
[TBL] [Abstract][Full Text] [Related]
7. An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3.
Edwards TL; Pericak-Vance M; Gilbert JR; Haines JL; Martin ER; Ritchie MD
Am J Med Genet B Neuropsychiatr Genet; 2009 Jul; 150B(5):721-35. PubMed ID: 19105203
[TBL] [Abstract][Full Text] [Related]
8. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data.
White CC; Yang HS; Yu L; Chibnik LB; Dawe RJ; Yang J; Klein HU; Felsky D; Ramos-Miguel A; Arfanakis K; Honer WG; Sperling RA; Schneider JA; Bennett DA; De Jager PL
PLoS Med; 2017 Apr; 14(4):e1002287. PubMed ID: 28441426
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of small ubiquitin-related modifier genes are associated with risk of Alzheimer's disease in Korean: A case-control study.
Mun MJ; Kim JH; Choi JY; Kim MS; Jang WC; Lee JJ; Eun YL; Kwak SJ; Kim KW; Lee SB
J Neurol Sci; 2016 May; 364():122-7. PubMed ID: 27084229
[TBL] [Abstract][Full Text] [Related]
10. LRRTM3 is dispensable for amyloid-β production in mice.
Laakso T; Muggalla P; Kysenius K; Laurén J; Paatero A; Huttunen HJ; Airaksinen MS
J Alzheimers Dis; 2012; 31(4):759-64. PubMed ID: 22710909
[TBL] [Abstract][Full Text] [Related]
11. Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.
Cruchaga C; Nowotny P; Kauwe JS; Ridge PG; Mayo K; Bertelsen S; Hinrichs A; Fagan AM; Holtzman DM; Morris JC; Goate AM;
Arch Neurol; 2011 Aug; 68(8):1013-9. PubMed ID: 21825236
[TBL] [Abstract][Full Text] [Related]
12. PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation.
Jun G; Asai H; Zeldich E; Drapeau E; Chen C; Chung J; Park JH; Kim S; Haroutunian V; Foroud T; Kuwano R; Haines JL; Pericak-Vance MA; Schellenberg GD; Lunetta KL; Kim JW; Buxbaum JD; Mayeux R; Ikezu T; Abraham CR; Farrer LA
Ann Neurol; 2014 Sep; 76(3):379-92. PubMed ID: 25043464
[TBL] [Abstract][Full Text] [Related]
13. Relationship between single nucleotide polymorphisms in the 3'UTR of amyloid precursor protein and risk of Alzheimer's disease and its mechanism.
Zhou Q; Luo L; Wang X; Li X
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30914454
[No Abstract] [Full Text] [Related]
14. Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease.
Lee JH; Cheng R; Rogaeva E; Meng Y; Stern Y; Santana V; Lantigua R; Medrano M; Jimenez-Velazquez IZ; Farrer LA; St George-Hyslop P; Mayeux R
Neurogenetics; 2008 May; 9(2):127-38. PubMed ID: 18340469
[TBL] [Abstract][Full Text] [Related]
15. Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).
Nowotny P; Simcock X; Bertelsen S; Hinrichs AL; Kauwe JS; Mayo K; Smemo S; Morris JC; Goate A
Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):469-74. PubMed ID: 17427190
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individuals.
Shang Z; Lv H; Zhang M; Duan L; Wang S; Li J; Liu G; Ruijie Z; Jiang Y
Oncotarget; 2015 Dec; 6(40):42504-14. PubMed ID: 26621834
[TBL] [Abstract][Full Text] [Related]
18. ADAM10 expression and promoter haplotype in Alzheimer's disease.
Bekris LM; Lutz F; Li G; Galasko DR; Farlow MR; Quinn JF; Kaye JA; Leverenz JB; Tsuang DW; Montine TJ; Peskind ER; Yu CE
Neurobiol Aging; 2012 Sep; 33(9):2229.e1-2229.e9. PubMed ID: 22572541
[TBL] [Abstract][Full Text] [Related]
19. No association of SORL1 SNPs with Alzheimer's disease.
Minster RL; DeKosky ST; Kamboh MI
Neurosci Lett; 2008 Aug; 440(2):190-2. PubMed ID: 18562096
[TBL] [Abstract][Full Text] [Related]
20. Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome.
Lee JH; Chulikavit M; Pang D; Zigman WB; Silverman W; Schupf N
Neurosci Lett; 2007 Sep; 425(2):105-9. PubMed ID: 17826910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
